--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--------
US Stock MarketDetailed Quotes
CTNM Contineum Therapeutics
- 17.805
- -0.895-4.79%
Close Oct 2 16:00 ET
458.00MMarket Cap-23183P/E (TTM)
18.860High16.830Low551.15KVolume18.860Open18.700Pre Close9.72MTurnover4.35%Turnover Ratio1618.64P/E (Static)25.72MShares22.00052wk High2.11P/B225.86MFloat Cap13.27052wk Low--Dividend TTM12.69MShs Float22.000Historical High--Div YieldTTM10.86%Amplitude13.270Historical Low17.643Avg Price1Lot Size
Contineum Therapeutics Key Stats
Contineum Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Contineum Therapeutics Earnings Reports
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data